LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of “Moderate Buy” by Brokerages

LivaNova PLC (NASDAQ:LIVN) has received an average recommendation of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $62.4286.

A number of brokerages recently commented on LIVN. The Goldman Sachs Group set a $55.00 price objective on shares of LivaNova and gave the company a “neutral” rating in a research report on Wednesday, October 1st. Needham & Company LLC reissued a “buy” rating and set a $64.00 target price on shares of LivaNova in a research note on Wednesday, September 3rd. Mizuho boosted their price target on shares of LivaNova from $65.00 to $70.00 and gave the company an “outperform” rating in a report on Thursday, November 13th. Barclays increased their price objective on LivaNova from $55.00 to $58.00 and gave the stock an “equal weight” rating in a report on Thursday, August 21st. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of LivaNova in a research report on Monday.

Institutional Investors Weigh In On LivaNova

Large investors have recently made changes to their positions in the company. GAMMA Investing LLC raised its position in LivaNova by 182.5% during the second quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock valued at $28,000 after acquiring an additional 407 shares in the last quarter. State of Wyoming bought a new stake in LivaNova in the second quarter worth approximately $31,000. EverSource Wealth Advisors LLC increased its stake in shares of LivaNova by 998.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 703 shares of the company’s stock worth $32,000 after purchasing an additional 639 shares during the last quarter. Quarry LP acquired a new position in shares of LivaNova during the 3rd quarter worth $36,000. Finally, UMB Bank n.a. raised its holdings in shares of LivaNova by 63.0% during the 3rd quarter. UMB Bank n.a. now owns 792 shares of the company’s stock valued at $41,000 after purchasing an additional 306 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

LivaNova Trading Down 1.9%

Shares of NASDAQ LIVN opened at $62.75 on Friday. LivaNova has a one year low of $32.48 and a one year high of $65.57. The firm has a market capitalization of $3.43 billion, a PE ratio of -15.69 and a beta of 1.02. The company has a current ratio of 1.33, a quick ratio of 1.12 and a debt-to-equity ratio of 0.30. The business has a 50-day moving average price of $56.25 and a two-hundred day moving average price of $51.53.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.